The Restlessness Gap: Why Pharma Can’t Afford to Wait on AI | Alex Condoleon, Pfizer

Published: 29 July 2026

What happens when doctors and patients adopt AI faster than pharma does?

In this episode of Off Label, Steve Royle sits down with Alex Condoleon, Chief Medical Affairs Officer of Medical Engagements & Impact at Pfizer, to unpack one of the most urgent challenges facing the industry: The Restlessness Gap.

Fresh from his standout keynote at NEXT Pharma Summit, Alex explores why healthcare feels increasingly restless, why business-as-usual is no longer enough, and why this moment demands a bolder, faster response from pharma — especially Medical Affairs.

They discuss:

• why AI is an unstoppable force in healthcare
• how HCP behaviour is changing in real time
• why pharma risks being left behind if it pauses now
• the strategic difference between productivity gains and true growth
• what liberated capacity from AI should actually be used for
• why Medical Affairs may be more relevant in this next era than ever before